ATE454151T1 - Arzneimittel für nicht-cardiogene diastolische dysfunktion - Google Patents

Arzneimittel für nicht-cardiogene diastolische dysfunktion

Info

Publication number
ATE454151T1
ATE454151T1 AT99902868T AT99902868T ATE454151T1 AT E454151 T1 ATE454151 T1 AT E454151T1 AT 99902868 T AT99902868 T AT 99902868T AT 99902868 T AT99902868 T AT 99902868T AT E454151 T1 ATE454151 T1 AT E454151T1
Authority
AT
Austria
Prior art keywords
cardiogenic
diastolic dysfunction
medicinal products
dysfunction
diastolic
Prior art date
Application number
AT99902868T
Other languages
English (en)
Inventor
Hisashi Kawasumi
Yuji Abe
Naoya Satoh
Yoshimi Kitada
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of ATE454151T1 publication Critical patent/ATE454151T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AT99902868T 1998-02-12 1999-02-10 Arzneimittel für nicht-cardiogene diastolische dysfunktion ATE454151T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2967898 1998-02-12
PCT/JP1999/000562 WO1999040919A1 (en) 1998-02-12 1999-02-10 Remedies for cardiac dilastolic disorders

Publications (1)

Publication Number Publication Date
ATE454151T1 true ATE454151T1 (de) 2010-01-15

Family

ID=12282784

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99902868T ATE454151T1 (de) 1998-02-12 1999-02-10 Arzneimittel für nicht-cardiogene diastolische dysfunktion

Country Status (8)

Country Link
EP (1) EP1062948B1 (de)
JP (1) JP4635339B2 (de)
KR (1) KR100571691B1 (de)
CN (1) CN1198617C (de)
AT (1) ATE454151T1 (de)
CA (1) CA2320627C (de)
DE (1) DE69941897D1 (de)
WO (1) WO1999040919A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100496495C (zh) * 2001-03-13 2009-06-10 三菱制药株式会社 糖尿病引起的缺血性心脏病的治疗和/或预防药
CN100502861C (zh) * 2001-07-25 2009-06-24 田边三菱制药株式会社 抑制钠/钙交换系统的药剂
WO2003011296A1 (fr) * 2001-07-30 2003-02-13 Mitsubishi Pharma Corporation Preparations pharmaceutiques stables contenant comme principe actif des derives de l'acide aminobenzenesulphonique
JPWO2004019946A1 (ja) * 2002-08-30 2005-12-15 三菱ウェルファーマ株式会社 細胞内ナトリウムイオン過蓄積抑制薬
WO2004022545A1 (ja) * 2002-09-06 2004-03-18 Mitsubishi Pharma Corporation 移植臓器保護剤
WO2004069275A1 (ja) * 2003-02-04 2004-08-19 Mitsubishi Pharma Corporation 眼科用剤
WO2008010567A1 (fr) * 2006-07-21 2008-01-24 Mitsubishi Tanabe Pharma Corporation Sel ou solvate d'acide 5-méthyl-2-(pipérazin-1-yl)benzènesulfonique
EP2050741A4 (de) * 2006-07-21 2009-10-28 Mitsubishi Tanabe Pharma Corp Kristalliner polymorphismus von 5-methyl-2-(piperazin-1-yl)benzolsulfonsäure

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686438B2 (ja) * 1989-03-27 1994-11-02 三菱化成株式会社 アミノベンゼンスルホン酸誘導体
JP3083544B2 (ja) * 1990-09-27 2000-09-04 三菱化学株式会社 心疾患を予防または治療する薬剤
JP3215338B2 (ja) * 1995-12-15 2001-10-02 三菱化学株式会社 アミノベンゼンスルホン酸誘導体一水和物及びその製造方法
CA2192731C (en) * 1995-12-15 2005-09-27 Chika Yamazaki Monohydrates of aminobenzenesulfonic acid derivatives and method for preparing thereof
JPH10298077A (ja) * 1997-04-24 1998-11-10 Mitsubishi Chem Corp 心筋症の治療、予防剤

Also Published As

Publication number Publication date
CN1296411A (zh) 2001-05-23
WO1999040919A1 (en) 1999-08-19
DE69941897D1 (de) 2010-02-25
KR20010040837A (ko) 2001-05-15
CA2320627A1 (en) 1999-08-19
CA2320627C (en) 2007-10-30
JP4635339B2 (ja) 2011-02-23
KR100571691B1 (ko) 2006-04-17
EP1062948A4 (de) 2002-07-17
EP1062948B1 (de) 2010-01-06
EP1062948A1 (de) 2000-12-27
CN1198617C (zh) 2005-04-27

Similar Documents

Publication Publication Date Title
NO2025027I1 (no) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
KR920019342A (ko) 골질환 치료제
DE69528005D1 (de) Prolineamid-Derivate
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
PT1401841E (pt) Derivados substituidos de 1-oxa-2,8-diaza-espiro[4.5]dec-2-eno como medicamentos para o tratamento da dor
MXPA05003253A (es) Nuevos derivados de pirimidinamida y el uso de los mismos.
TR200100895T2 (tr) Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı
NO20006646L (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
ATE454151T1 (de) Arzneimittel für nicht-cardiogene diastolische dysfunktion
IT1318514B1 (it) Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
SE0002729D0 (sv) Novel compound form
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
NO20031410L (no) Anvendelse av distamycinderivater for fremstilling av medikamenter
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
MXPA05014143A (es) Derivados de cumarina para el tratamiento de trastornos oftalmicos.
AP9901474A0 (en) Pharmaceutical composition for treating viral diseases.
PT855398E (pt) Derivados sasquiterpeno tendo actividade antiviral
BR0108002A (pt) Derivados de amidas heterocìclicas
NO20041878L (no) Karboksylsyrederivat-forbindelser og legemidler inneholdende de samme som den aktive bestanddel.
EE200200215A (et) 2-amino-3,4-dihüdrokinasoliinide kasutamine ravimi valmistamiseks, mis on ette nähtud isheemilistest seisunditest tingitud haiguste raviks või ennetamiseks
ID20165A (id) Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis
EP1234576A4 (de) Heilmittel gegen essstörungen
DE60233647D1 (de) Reduziertes vitamin b2 enthaltende arzneimittel
NO20030474D0 (no) Demens-legemiddel som inneholder 2-aryl-8- oksodihydropurinderivater som denaktive bestanddel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties